CTNM
Contineum Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.79
+1.03%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-25.9%
Return on equity
-24.7%
Return on assets
-28.8%
Return on invested capital
0.00x
Asset turnover
-$51.9M
Cash from operations
$6.23
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026